Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer.
Mónica Wilhelm, Joris Andre Veltman, Adam B. Olshen et al. · PubMed · 2002
Array-based comparative genomic hybridization (CGH) uses multiple genomic clones arrayed on a slide to detect relative copy number of tumor DNA sequences. Application of array CGH to tumor specimens makes genetic diagnosis of cancers possible and may help to differentiate relevant subsets of tumors, biologically and clinically, which would allow better prognostic and therapeutic decision making. In this study, we have used array-based CGH to detect DNA copy number alterations in distinct types of renal cell carcinomas for diagnostic purposes. We were able to correctly diagnose 33 of 34 malignant tumors by automated computational means and to group together eight benign neoplasms and normal kidney samples. These results indicate that array-based CGH is capable of diagnosing the vast majority of renal cell carcinomas based on their genetic profiles.
Cited by 182 works.
Authors
- Mónica Wilhelm
- Joris Andre Veltman
- Adam B. Olshen
- Ajay N. Jain
- Dan H. Moore
- Joe C Presti
- Gyula Kovács
- Frederic M. Waldman
References
- Pattern classification and scene analysis
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
- Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
- High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
- Genome-wide analysis of DNA copy-number changes using cDNA microarrays
- The Heidelberg classification of renal cell tumours
- Integration of cytogenetic landmarks into the draft sequence of the human genome
- Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances